Seroprevalence of Hepatitis B and C Viruses and Association with Biochemical Parameters among Patients Tested for Viral Hepatitis in Cumilla, Bangladesh: A Cross-sectional Study
Biplob Chandra Sarker
Department of Microbiology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Md Ranzu Ahmed *
Department of Chemistry, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Najat Ahmed
Department of Microbiology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Israt Jahan
Department of Health Promotion & Health Education, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Nadia Ahmed
Department of Biochemistry and Cell Biology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Shupriti Khandker
Department of Biochemistry and Cell Biology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
Kaniz Laila Shams
Department of Radiology Imaging, BIHS General Hospital, Dhaka, Bangladesh.
Md Mamun Ul Islam Khan
Department of Medicine, BIHS General Hospital, Dhaka, Bangladesh.
Md Jahangir Alam Sarker
Department of Medicine, BIHS General Hospital, Dhaka, Bangladesh.
Shah Md. Zahurul Haque Asna
Department of Microbiology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
*Author to whom correspondence should be addressed.
Abstract
Background: Viral hepatitis, caused mainly by hepatitis B virus (HBV) and hepatitis C virus (HCV), is a leading cause of liver-related morbidity and mortality worldwide, contributing to an estimated 1.3 million deaths annually. Bangladesh is considered intermediate-endemic for HBV, yet data on the proportion of viral hepatitis and associated biochemical alterations among patients in downtown Cumilla remain scarce.
Objective: To determine the proportion of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among patients tested for viral hepatitis in downtown Cumilla, Bangladesh, and to examine their association with age, sex, and biochemical parameters (SGPT/ALT and serum bilirubin).
Methods: A cross-sectional, laboratory-based study was conducted among 100 patients who attended selected diagnostic centres and healthcare facilities in downtown Cumilla for viral hepatitis testing between January and August 2026, who were recruited consecutively using convenience sampling. Age, sex, HBsAg, Anti-HCV, serum glutamic pyruvic transaminase (SGPT/ALT) and serum bilirubin were obtained from laboratory reports and patient records. Associations were analysed using chi-square tests (with continuity correction for 2×2 tables) and independent-samples t-tests, with p<0.05 considered significant. The study used anonymized, routinely collected records, and no separate ethics committee approval was obtained.
Results: The mean participant age was 42.99 ± 19.91 years; 62% were male. HBsAg was positive in 47.0% of participants (95% CI 37.5–56.7%), whereas no participant tested positive for Anti-HCV. HBsAg positivity did not differ significantly by age group (p=0.294) or sex (p=0.276); it was 55.3% among females and 41.9% among males. HBV-positive participants had significantly higher mean SGPT levels than HBV-negative participants (175.00 ± 155.45 U/L in the HBV-positive group; p=0.048), whereas bilirubin levels showed no significant difference (p=0.887).
Conclusion: Among patients tested for viral hepatitis in Cumilla, HBsAg positivity was high and was associated with higher SGPT levels, whereas HCV infection was not detected. Because participants were facility-based patients and not a community sample, these figures should not be generalised to the general population. Strengthened screening, vaccination, and public awareness are needed to reduce the burden of HBV-related liver disease.
Keywords: Viral hepatitis, hepatitis B virus (HBV), HBsAg, serum glutamic pyruvic transaminase (SGPT), anti-HCV